BOSTON, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced a ...
– Prioritization of Phase 2-ready clinical-stage programs: RLYB212 for the prevention of FNAIT and RLYB116, a C5 inhibitor for the treatment of patients with complement-mediated diseases – – ...
Leaders often grapple with the feeling that there simply aren’t enough hours in a day. They want to think strategically, plan for the future and invest time in reflecting on their team’s direction, ...
This is a RAPS-SF Executives event exclusive for VP and above. This facilitated roundtable discussion event brings together industry leaders to explore how organizations are navigating two critical ...
New AI-native capabilities help organizations continuously prioritize initiatives, reduce redundancy, and move from idea to execution-ready plans faster. Enterprises aren't short on AI ideas. Business ...
The work of portfolio analysis is becoming ever more demanding. The volume and complexity of the tasks required to create, analyze, edit and report on investment portfolios is rising rapidly.
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB) today announced the prioritization of its portfolio and a 45% workforce reduction to focus resources on its Phase 2-ready ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results